Analysis of the relationship between fetal magnetic resonance imaging indications and findings with ultrasonographic examination

Objectives: We aimed to examine the indications for the use of fetal MRI in obstetrics practice and the relationship between fetal MRI and ultrasonographic findings. Methods: Seventy-three patients were examined with Fetal MRI for various reasons between July 2017 and July 2020, and whose results were available were evaluated retrospectively. Ultrasonographic and MRI findings were recorded. The detected pathologies were divided into groups according to systems. The relationship between the findings was examined. Results: In our study, ultrasonographic findings of fifty-five (75.3%) cases were confirmed by MR findings. MRI detected additional findings in eight (10.9%) cases, most of which were intracranial pathologies. The most detected ultrasonographic findings as an indication for the request were in the intracranial region (54.8%). Conclusions: Fetal MRI indications in perinatal care and follow-up are not clear. Determining these indications is also essential in preventing unnecessary use in obstetric practice and determining the cost-effectiveness.

___

  • 1. Chalouhi GE, Millischer A-E, Mahallati H, Siauve N, Melbourne A, Grevent D, et al, The use of fetal MRI for renal and urogenital tract anomalies. Prenat Diagn 2020;40:100-9.
  • 2. Patenaude Y, Pugah D, Lim K, Morin L, Bley S, et al; Diagnosetic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can 2014;36:349-63.
  • 3. Santos, XM, Papanna R, Johnson A,Cass DL, Olutoye OO, Moise KJ Jr, et al. The use of combined ultrasound and magnetic resonance imaging in the detection of fetal anomalies. Prenat Diagn 2010;30:402-7.
  • 4. Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, et al.; MERIDIAN collaborative group. Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study. Lancet 2017;389:538-46.
  • 5. Quinn TM, Hubbard AM, Adzick NS. Prenatal magnetic resonance imaging enhances fetal diagnosis. J Pediatr Surg 1998;33:553-8.
  • 6. Sotiriadis A, Makrydimas G. Neurodevelopment after prenatal diagnosis of isolated agenesis of the corpus callosum: an integrative review. Am J Obstet Gynecol 2012;206:337.e1-5.
  • 7. Robinson I. Fetal magnetic resonance imaging: a valuable diagnostic tool. Infant 2009;5:124-6.
  • 8. Rossi A, Prefumo F. Additional value of fetal magnetic resonance imaging in the prenatal diagnosis of central nervous system anomalies: a systematic review of the literature. Ultrasound Obstet Gynecol 2014;44:388-93.
  • 9. Mansour S, Elkhyat W. Placenta previa-accreta: do we need MR imaging? Egypt J Radiol Nucl Med 2011;42:433-42.
  • 10. Mar WA, Berggruen S, Atueyi U, Sekhon S, Garzon SA, Knuttinen MG, et al., Ultrasound imaging of placenta accreta with MR correlation. Ultrasound Q 2015;31:23-33.
  • 11. Tsai PJS, Loichinger M, Zalud I. Obesity and the challenges of ultrasound fetal abnormality diagnosis. Best Pract Res Clin Obstet Gynaecol 2015;29:320-7.